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Abstract
Background Self-care is assumed to benefit physiological function associated with prognosis in patients with chronic HF, but
studies examining these relations are lacking. This study aims to prospectively examine the association of self-reported HF self-
care with HF-associated pathophysiological markers, including renal, hematological, and immune function.
Method Patients with chronic HF (n = 460, 66.2 ± 9.6 years, 75%men) completed questionnaires and provided blood samples at
baseline and 12-month follow-up. Linear mixed models examined random intercept and fixed between- and within-subjects
effects of global self-care and the individual self-care behaviors on log-transformed TNF-α, IL-6, and IL-10, the glomerular
filtration rate of creatinine (GFRcreat), and hemoglobin (Hb), controlling for sociodemographic and clinical covariates.
Results Self-care was independently associated with lower GFRcreat levels (β = − .14, P = .023) and improvement in self-care
with a reduction in GFRcreat (β = − .03, P = .042). Individual self-care behaviors were differentially associated with renal,
inflammatory, and hematological markers. Regular exercise was associated with level differences in IL-6 (P < .001), and im-
provement in exercise was associated with increasing GFRcreat (P = .002) and increasing Hb (P = .010). Fluid restriction was
associated with lower overall GFRcreat (P = .006), and improvement in fluid restriction was associated with decreasing GFRcreat
(P = .014). Low-sodium intake was associated with lower levels of Hb (P = .027), lower TNF-alpha (P = .011), and lower IL-10
(P = .029). Higher levels of medication adherence were associated with reduced pro-inflammatory activation (P < .007).
Conclusion Our findings suggest that better global self-care was associated with poorer renal function. Performing self-care
behaviors such as regular exercise and medication adherence was associated with improved physiological functioning, while
restriction of fluid and sodium, and the associated daily weight monitoring were associated with adverse levels of pathophysi-
ological biomarkers.
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Introduction
Chronic heart failure (HF) is among the leading causes of
mortality in developed countries, affecting about 15 million
people across Europe [1, 2]. HF prevalence is expected to
increase due to the aging of the population, placing a signifi-
cant clinical and economic societal burden [3]. Despite thera-
peutic advances showing the ability to reduce admission rates
for HF [4, 5], effective management of HF remains challeng-
ing for both health care providers and patients. In addition to
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medical treatment, patients with HF are recommended to per-
form a complex regimen of multiple self-care behaviors (i.e.,
sodium and fluid restriction, regular exercise, medication ad-
herence, monitoring and consulting for HF symptoms) [6].
It is assumed that HF self-care is associated with better
health outcomes, but the available evidence is inconsistent
[7]. Potential mechanisms have been proposed suggesting that
self-care benefits HF outcomes via neurohormonal and in-
flammatory function [8]. To date, only one cross-sectional
study on 168 patients with HF has been published showing
an association between self-care management and reduced
myocardial stress and systemic inflammation [9].
Intriguingly, those reporting to be highest in self-care manage-
ment were at increased risk for myocardial stress and inflam-
mation. However, findings were cross-sectional and restricted
to self-care management; no associations were found for other
elements of self-care such as dietary restrictions.
Emerging evidence shows the prognostic importance of
cardiorenal and hematological function in patients with HF
[10]. Due to chronic volume overload, HF is associated with
progressive renal dysfunction, impaired renal perfusion, and
excessive production of vasoconstrictive neurohormones [11].
Renal dysfunction and associated elevated inflammation may
lead to a decrease in erythropoietin levels and reduced hema-
topoietic proliferation, evolving into anemia [12]. Chronic
anemia is associated with reduced tissue oxygenation, which,
in HF patients, results in hemodynamic compensatory re-
sponses to enhance oxygen-carrying capacity, thereby wors-
ening cardiac function. As self-care behaviors such as fluid
and salt restriction intend to reduce volume overload and
avoid decompensation, self-care might affect three important
mechanistic pillars of HF disease progression, i.e., inflamma-
tion, renal dysfunction, and anemia.
No prior study has examined the longitudinal relationship
between self-care and these pathophysiological markers of
HF disease severity [13]. Therefore, we aimed to prospec-
tively examine the association of self-reported HF self-care
with systemic inflammation (i.e., serum levels of tumor ne-
crosis factor alpha (TNF-α), interleukin-6 (IL-6), and IL-
10), renal function (i.e., estimated glomerular filtration rate
of creatinine (GFRcreat), and hemoglobin (Hb), respectively)
at inclusion and 1-year follow-up. We hypothesized that
poorer self-care would be associated with increased inflam-
mation, poorer renal function, and more anemia, as these
behaviors are directed at promoting allostatic balance [6].
Moreover, based on the argumentation set out above, we
expected the pathophysiological markers to be differentially
associated with individual self-care behaviors, as exercise
affects different pathophysiological pathways than fluid
and salt restriction. We expected exercise to be associated
with altered inflammatorymarkers [14],while limiting fluids
and salt intake should be associated with improved renal and
hemoglobin function [15].
Methods
Study Population and Design
Consecutive outpatients with chronic HF were recruited from
two cohorts from three general hospitals in the Netherlands.
The design and procedure of patient inclusion have been pub-
lished previously [16, 17]. Inclusion criteria were as follows: a
confirmed diagnosis of HF with a reduced left ventricular
ejection fraction (LVEF) ≤ 40%, New York Heart
Association (NYHA) function classes I–III, stable on HF
medication, and age ≤ 80 years. Exclusion criteria were as
follows: a hospital admission 1 month prior to inclusion, other
life-threatening conditions with a life expectancy < 1 year,
severe psychiatric comorbidity (except for anxiety and/or de-
pression), severe cognitive impairment, or insufficient compe-
tence of the Dutch language [16, 17]. The cardiologists or HF
nurses approached eligible patients for participation during an
outpatient clinic visit. An independent study investigator
called invited patients to schedule a baseline appointment in
which they were given additional information about the study
protocol before signing informed consent. At baseline and at
12-month follow-up, participants completed questionnaires at
home to assess socio-demographic and psychological vari-
ables including HF self-care that were returned within 2 weeks
by mail in a stamped and pre-addressed envelope.
Questionnaires were checked for completeness. Participants
were contacted in the event of a missing questionnaire or
items. Venous blood samples were drawn for cytokine mea-
surement and clinical laboratory values during daytime in a
planned outpatient clinic visit at baseline and 12-month fol-
low-up. Participants were instructed not to exercise, smoke, or
drink prior to their blood draws and were told to reschedule
when ill (cold or fever).
In total, 709 patients were eligible to participate. Data orig-
inated from two observational cohort studies for which ethics
approval was obtained from the relevant medical ethics com-
mittees. The investigation conforms to the principles outlined
in the Declaration of Helsinki (2013).
Self-Care
The 9-item European Heart Failure Self-care Behavior scale
(EHFScB-9) [16] assessed self-care at baseline and 12-month
follow-up. Items were rated on a 5-point Likert scale from 1
(“I completely agree) to 5 (“I completely disagree”). Item
scores were reversed in order to calculate sum scores (range
9–45). Scores were then transformed into a standardized score
from 0 to 100 [18, 19], with higher scores reflecting better
self-care. The EHFScB-9 includes a 4-item “consulting be-
havior” subscale measuring whether patients contact their
doctor/nurse in case of shortness of breath, ankle swelling,
weight gain, and fatigue. The internal consistency of the total
Int.J. Behav. Med.
self-care scale and the consultation behavior scale in the cur-
rent database at baseline and 12-month follow-up was good,
with Cronbach’s α = .79 for the total scale, α = .86 for the
consulting scale. Test retest reliability for these two scales
was moderate with the intra-class correlation being .66 for
the total score and .60 for the consultation behavior scale. In
addition to the two scale scores, scores on individual self-care
behaviors (single items: weight monitoring, fluid restriction,
salt restriction, medication adherence and regular exercise)
were analyzed. Intra-class correlations were .61 for daily
weight monitoring, .47 for fluid restriction, .55 for salt restric-
tion, .65 for regular exercise, and .11 for medication adherence
(potential ceiling effect: 310 of the 391 patients with follow-
up data scored the maximum score of 5 on the medication
adherence item at both time points). These ICC results suggest
that there is a moderate amount of stable between- and within-
person variance, leaving sufficient room for a reliable change
prediction.
To be able to discriminate between between- and within-
subjects effects, for all self-care scores, we calculated a person
mean, reflecting the average level of self-care, consultation
behavior, or adherence to specific health behaviors across
time. This variable was used to assess between-subject differ-
ences. We also calculated the time-specific deviation from the
person mean to use as the independent variable for within-
subjects effects.
Socio-demographic and Clinical Characteristics
Socio-demographic variables were assessed at baseline
using purpose-designed items including educational level
(primary school or less vs. > 8 years of education), cur-
rent smoking, marital (alone vs. having a partner), and
employment status (yes/no). Patients’ medical records
were searched for information on body mass index
(BMI), disease characteristics (i.e., (ischemic) etiology,
LVEF, NYHA function classes I–II vs. III), cardiac his-
tory of previous myocardial infarction, percutaneous cor-
onary intervention, or coronary artery bypass graft sur-
gery, and pharmaceutical treatment (e.g., beta-blockers,
angiotensin-converting enzyme inhibitors, angiotensin re-
ceptor blockers, diuretics, and aspirin). The presence of
the following medical comorbidities was documented:
diabetes, chronic obstructive pulmonary disease, periph-
eral arterial disease, hypertension, hypercholesterolemia,
gastrointestinal disease, cancer, cerebrovascular disease
including transient ischemic attack, liver disease, and re-
nal failure.
Measurements
Venous blood samples were drawn at baseline and at 12-
month follow-up. Procedures have extensively been published
before [20, 21]. Renal function was measured according to the
K/DOQI guidelines [22, 23] by calculating the glomerular
filtration rate of creatinine. The MDRD equation defined as
GFRcreat < 60 ml/min per 1.73 m
2 was used to define renal
dysfunction [20]. Inflammatory biomarker data (TNF-α, IL-6,
and IL-10) were available for a subsample, as the blood
substudy started later, and obtained using standard hospital
protocol. Patients with rheumatic arthritis or gout were not
eligible for the cytokine analyses, due to the chronic inflam-
mation characteristic of these comorbidities. Blood was
allowed to clot at room temperature for at least 20 min and
centrifuged. Aliquoted serum samples were stored at − 80 °C
in anticipation of further processing. Concentrations of IL-6
(sensitivity: 2 pg/ml), IL-10 (sensitivity: 1 pg/ml), and TNF-α
(sensitivity: 1.7 pg/ml) were measured using a solid-phase,
enzyme-labeled, chemiluminescent immunometric assay
(Immulite 1000, Siemens Healthcare Diagnostics Breda, the
Netherlands). All tests were measured in accordance with the
manufacturer’s recommendations. The intra-assay variation
was less than 10%, and the inter-assay variation less than
11%. Plasma hemoglobin (Hb) was determined using the
Siemens ADVIA 120 Hematology system in the hospitals’
central Clinical Chemistry & Hematology Laboratory as an
indicator of anemia [21]. Continuous levels of Hb were used
in the analyses.
Statistical Analysis
All biomarkers were tested for outliers of > 3 SDs, which
were considered erroneous and thus removed (Hb: T0: n =
1, T12m: n = 1; GFRcreat: T0: n = 2, T12m: n = 1; TNF-
alpha: T0: n = 3, T12m: n = 4; IL-6: T0: n = 4, T12m: n =
4, IL-10: T0: n = 11, T12m: n = 11 (both including below
detection limit)). Prior to running analyses, skewed data
were log-transformed. Group differences in baseline char-
acteristics were analyzed for (a) patients with and without
complete data at baseline/12-month follow-up and for (b)
patients with and without biomarker data on both time
points using Student’s t tests for independent samples and
chi-square tests (Fischer’s exact test when appropriate) for
continuous and discrete variables, respectively. Descriptive
baseline statistics were calculated and correlated with base-
line self-care by calculating Pearson (continuous variables
or Spearman (dichotomous variables)) correlations.
Repeated measures ANOVA analyses were run to establish
whether self-care behavior significantly changed from
baseline to 12 months follow-up. Pearson correlations were
calculated for baseline levels of GFRcreat, Hb, TNF-α, IL-
10, and IL-6 with individual self-care behaviors at baseline
and at 12 months follow-up.
For the main analyses, separate linear mixed models
with maximum likelihood estimation (Satterthwaite ap-
proximation for df calculation (standard in SPSS)) were
Int.J. Behav. Med.
used to examine longitudinal associations of the person mean
of continuous self-care (i.e., average of the two measurement
occasions; to gauge between-subject effects) and the time-
specific deviation of the self-care score from the person mean
(reflecting within-subject differences) with continuous levels
of pathophysiological markers (dependent variables with re-
peated measures) of renal and hematological function and
inflammation at baseline and 12-month follow-up. The linear
mixed modeling technique is suitable for analysis of repeated
measurements, as it takes the possibility of correlated data into
account. In addition, in contrast to traditional repeated mea-
sures ANOVA, one missing measurement occasion does not
automatically lead to exclusion of that patient from analysis,
limiting bias and preserving statistical power. Another advan-
tage to linear mixed modeling analysis is the possibility of
measuring variables as fixed variables or as time-varying var-
iables. Self-care was added as a time-varying predictor. We
added a random intercept to gauge to potential effect of im-
portant unmeasured explanatory variables. As an indication of
effect size, standardized estimates (β) were calculated for
main self-care effects and their interactions in excel using
the standard deviations (DV, IV) and raw estimates. In the first
models, time and self-care (between and within) were added
as predictors of the level of each pathophysiological marker
across time. Second, we adjusted for a priori chosen socio-
demographic and health behavioral fixed covariates, chosen
for their established association with the pathophysiological
marker of interest and/or self-care, including age, sex, partner
status, education, current smoking status, BMI, and diabetes
[12]. Then, we adjusted for HF disease severity (NYHA func-
tion class and LVEF), time since diagnosis in years, and pre-
scribed medication (i.e., angiotensin-converting enzyme in-
hibitors or angiotensin receptor blockers, beta-blocking
agents, and diuretics for GFRcreat and Hb [12]; aspirin and
beta-blocking agents for inflammatory cytokines). Finally,
we added the interaction of self-care with time to gauge
within-subject effects of self-care on the course of the bio-
markers. To examine the relative contribution of each self-
care behavior to the concentrations of pathophysiological
markers, multivariable linear mixed models were repeated
with the person mean and deviation score over time of the
consultation subscale and the individual self-care item scores
for each pathophysiological outcome as a time-varying depen-
dent variable. Resulting estimates indicate the change in the
dependent variable when the independent variable increases
with one point, and equals B. A P value < .05 was considered
of statistical significance. To reduce the chance of false dis-
covery by multiple testing (subscale and individual behav-
iors), we applied the Benjamini-Hochberg procedure to the
P values [24]. All analyses were performed using IBM
SPSS Statistics version 24 (IBM Corp. Released 2016. IBM




A flowchart of inclusion is presented in Fig. 1. In total, 709
patients were eligible and invited to participate in the study of
which 548 patients (77%) finally participated. Blood collec-
tion at baseline was not available for 52 participants due to
delay in the start of the blood collection sub study, and 36
participants were excluded due to missing data on any of the
baseline clinical variables or questionnaires. The final baseline
survey sample for the current paper thus included 460 partic-
ipants (mean age 66.2 ± 9.6 years, 75% male sex) with com-
plete data at baseline. There were no differences in responders
vs. non-responders in socio-demographic baseline character-
istics, nor were there differences between included and ex-
cluded (n = 88) patients in any of the socio-demographic char-
acteristics. With respect to clinical characteristics, excluded
patients were characterized by a poorer LVEF (30% vs.
32%, P = .016) and increased prescription of diuretics (85%
vs. 73%, P = .016) compared with included patients.
At follow-up, we retained 391 patients with survey and
clinical data, indicating an overall attrition rate of 15%.
GFRcreat was available for 448 patients at baseline, and 391
patients at follow-up (13% loss to follow-up). Data on inflam-
matory biomarkers were available in a subsample of 316 pa-
tients at baseline and 226 patients at follow-up (28% loss to
follow-up/outliers/below detection limit). Patients with valid
inflammatory markers present were characterized by a higher
LVEF (32% vs. 30%, P < .001) and a better NYHA function
class (I–II class: 81% vs. 50%, P < .001), but more likely to
have COPD (20% vs. 13%, P = .025) compared with patients
for whom no inflammation data was available.
Patients with complete baseline and follow-up question-
naire data were in better condition, indicated by less NYHA
class III participants (45% vs. 28%;χ2 = 19.48,P < 001) and a
lower comorbidity burden (diabetes: 35% vs. 26%, χ2 = 3.38,
P = .07; COPD: 24% vs. 15%, χ2 = 3.82, P = .051; kidney
disease: 45% vs. 32%; %; χ2 = 3.89, P = .048), compared to
patients who dropped out. Patients with complete baseline and
follow-up questionnaire data did not differ from patients who
dropped out with respect to baseline global self-care scores,
consultation behavior scores, and individual behaviors at
baseline.
Socio-demographic and clinical baseline characteristics of
the final sample are presented in Table 1, including correla-
tions with baseline self-care. Better baseline self-care was as-
sociated with the presence of ischemic etiology, a shorter time
since diagnosis, absence of cardiac history, the presence of
diabetes, and the use of diuretics. Moreover, better self-care
was associated with participation in cardiac rehabilitation,
non-smokers, and lower BMI. Table 2 shows the averages of
the two standardized self-care scores (global and consultation)
Int.J. Behav. Med.
and the five individual self-care behaviors. The averages for
global self-care and consultation behavior were a bit higher at
12 months follow-up, and not significantly so, but the stan-
dard deviations were large, suggestive of large variation.
Scores for individual behaviors were similar for the two time
points. Splitting the group into patients who improved their
self-care behaviors, patients whom had equal scores at both
time points, and patients with declined in their reported self-
care showed important insights. Patients with a decline in
reported global self-care showed significant (all P < .01) re-
ductions in all aspects of self-care. With respect to the indi-
vidual self-care behaviors, the reduction seems most pro-
nounced in daily weight monitoring and salt restriction.
Patients who increased their self-care behavior (i.e., improved
scores) also improved significantly across the board (all
P < .01). With respect to individual behaviors, daily weight
monitoring and fluid and salt restriction contributed most to
the improvement. Table 3 shows change in the non-
transformed levels (descriptive purposes) of pathophysiologi-
cal outcome markers for patients who improved, deteriorated,
and remained at an equal level of self-care.
Global Self-Care and Pathophysiological Outcomes
Linear mixedmodeling results showed that GFRcreat levels did
not change significantly over time (F(1,311.05) = .42,
P = .518) (Table 4). In unadjusted analysis, higher (i.e., better)
levels of total self-care were associated with a lower GFRcreat
Fig. 1 Flowchart of inclusion
Int.J. Behav. Med.
Table 1 Baseline characteristics
for total sample and correlations
with global self-care
Total (n = 460) Correlation with baseline self-care P value
Sociodemographic variables
Age, mean ± SD (years) 66.2 ± 9.6 .01
.869
Male gender 344 (75) .07
.120
Having a partner 345 (75) .07
.099
Currently employed 67 (15) − .06
.136
Low education* 157 (34) .07
.085
Clinical variables
Etiology (ischemic) 271 (59) .09
.042
Time since diagnosis (years)‡ 4.5 ± 4.8 − .12
.011
LVEF, mean ± SD (%) 31.8 ± 6.8 − .01
.773
NYHA class III 146 (32) − .02
.683
Cardiac history† 288 (63) − .11
.009
Hyperlipidemia 268 (58) .02
.731
Hypertension 195 (42) .07
.096
Peripheral arterial disease 67 (15) .02
.570
Diabetes mellitus 122 (27) .10
.017
COPD 76 (17) − .01
.854
Kidney disease 55 (12) .08
.051
Stroke/transient ischemic attack 68 (15) .03
.562
Implantable device (yes) 70 (16) .03
.473
Health behaviors
Currently smoking 108 (24) − .13
.003
BMI, mean ± SD 28.0 ± 5.1 − .11
.015
Cardiac rehabilitation 36 (8) .11
.009
Prescribed medications
Beta-blockers 303 (66) .08
.070
ACEi 314 (68) .02
.570
ARBs 115 (25) .05
.301
Calcium antagonists 58 (13) .05
.259
Oral anticoagulants 237 (52) .03
Int.J. Behav. Med.
(F(1,369.87) = 6.43; β = − .15, P = .012), indicative of an
overall poorer renal function. Within-subject increase in over-
all self-care over the 1-year period was related to a slightly
poorer renal function as well (F = (1310.65) = 4.06; β = − .03,
P = .045). Adding baseline socio-demographic and health be-
havioral covariates did not affect the results. In the fully ad-
justed model, better overall self-care and increase in self-care
over the follow-up period both remained associated with low-
er GFRcreat (Fbetween(1364.50) = 5.19; β = − .14, P = .023) and
decreasing GFRcreat (Fwithin(1306.42) = 4.19; β = − .03,
P = .042) respectively, beyond clinical covariates. Significant
covariates of decreased GFRcreat were higher age, lower
LVEF, and prescribed diuretics. Finally, adding the interac-
tions of time with the person mean of self-care and its time-
specific deviations resulted in the observation that in addition
to their main effects, there was a trend interaction of the person
mean of self-care with time (F(1,306.97) = 3.45, β = .03,
P = .06, B = − .08). In this final adjusted model, the random
intercept was significant (Wald = 12.06, P < .001) and of sub-
stantial size (variance estimate = 928.96, se = 73.61), suggest-
ing there remain important other variables that determine the
level of GFRcreat that were not included in our study.
Hb concentrations were stable across the 12-month time
period (F(1,357.31) = 1.68, P = .195). The overall level of





Improved self-care (N = 184) Equal self-care (N = 41) Reduced self-care (N = 186)
BL 12mo BL 12mo BL 12mo
Standardized scores (0–100, with higher scores signifying better adherence)
Total self-care score 62.3 (21.6) 64.4 (19.9) 54.7 (20.3) 70.0 (17.0) 67.5 (23.6) 67.5 (23.6) 72.2 (18.0) 58.9 (20.0)
Consultation behavior score 60.5 (31.3) 64.0 (30.0) 51.6 (30.5) 71.4 (26.1) 66.6 (33.5) 65.5 (34.5) 74.2 (25.1) 56.8 (30.6)
Individual behaviors (lower scores = better adherence)
Weight monitoring 3.6 (1.5) 3.5 (1.5) 3.8 (1.4) 3.3 (1.5) 3.3 (1.6) 3.2 (1.7) 3.2 (1.6) 3.8 (1.5)
Fluid restriction 2.4 (1.4) 2.3 (1.4) 2.8 (1.4) 2.2 (1.3) 2.1 (1.3) 2.0 (1.3) 1.9 (1.1) 2.3 (1.4)
Salt restriction 2.4 (1.4) 2.4 (1.4) 2.8 (1.4) 2.2 (1.3) 2.2 (1.4) 2.2 (1.5) 2.1 (1.3) 2.7 (1.4)
Medication adherence 1.3 (.8) 1.2 (.6) 1.4 (.9) 1.1 (.2) 1.2 (.6) 1.2 (.6) 1.1 (.4) 1.4 (.8)
Regular exercise 2.6 (1.3) 2.6 (1.3) 2.8 (1.3) 2.6 (1.3) 2.6 (1.4) 2.6 (1.5) 2.5 (1.4) 2.7 (1.3)
Improved self-care indicates higher global self-care levels at 12 months follow-up, equal self-care indicates the group patients with the same global self-
care score at both time points, and reduced self-care indicates lower global self-care levels at 12 months follow-up
Table 1 (continued)
Total (n = 460) Correlation with baseline self-care P value
.560
Statins 258 (56) .02
.614
Diuretics 336 (73) .13
.003
Nitrates 148 (32) .01
.880
Aspirin 183 (40) − .05
.275
Psychotropic medication 72 (16) − .03
.639
Data are presented as n (%) unless stated otherwise. The second and third columns hold the Pearson (continuous
variables) and Spearman (dichotomous variables) correlations, with baseline self-care, and accompanying P
values. Boldfaced numbers represent significant differences (P<.05), while italic numbers represent trends
(P<.10).
ACEi angiotensin-converting enzyme inhibitors, ARBs angiotensin receptor blockers, BMI body mass index,
COPD chronic obstructive pulmonary disease, LVEF left ventricular ejection fraction, NYHA New York Heart
Association, SD standard deviation, N may vary slightly per variable due to missing data
*Primary school or less
†History of myocardial infarction, percutaneous coronary intervention, or coronary artery bypass graft surgery
‡N = 36 missing values
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self-care was not associated with Hb in both unadjusted
(F(1,717.90) = .25; β = − .06, P = .618) and adjusted models
(model 3: F(1,382.83) = .19; β = − .02, P = .662). Positive
within-person change in self-care was associated with a trend
improvement in hemoglobin in both the unadjusted
(F(1,336.79) = 3.11; β = .04, P = .079) and fully adjusted
model (F(1,341.54) = 3.20; β = .04, P = .075). Significant co-
variates of poorer Hb concentrations in the final model were
NYHA function class III, presence of diabetes, prescribed
diuretics, lower BMI, and female sex. There were no signifi-
cant interactions between time and self-care. In the final mod-
el, the random intercept was significant (Wald = 9.35,
P < .001), with a variance estimate of .43 (se = .05).
Time effects differed per type of cytokine. In unadjusted
models, there was no significant effect of time for TNF-α
(F(1,237.39) = 1.85, P = .186), while IL-6 decreased signifi-
cantly (F(1, 212.10) = 10.34, P = .002) and IL-10 increased
(F(1,238.09) = 18.41, P < .001), indicative of less Th2 inflam-
matory activity. There were no significant between- and
within-subject effects of global self-care on the levels of any
of the cytokines in both unadjusted (data not shown) and ad-
justed mixed models. In the covariate models, higher age was
associated with increased TNF-α and IL-6, and presence of




Pearson correlations of the individual self-care behaviors with
the pathophysiological outcomes at baseline and 12-month
follow-up are presented in Fig. 2. Adherence to the medication
regime and being physically active regularly were correlated
with lower cytokine levels and higher GFRcreat and Hb.
Increased weight monitoring, fluid and salt restriction corre-
lated with increased inflammatory activity and poorer renal
and hematological function on one or both of the measure-
ment occasions.
Next, multivariable linear mixed models were run for
each pathophysiological marker to examine the associa-
tion with the self-care behaviors while adjusting for the
same covariates as tested in the models for the global
self-care score (Table 5). Correlations among the individ-
ual self-care items were moderate (r = .07–.40), therefore
not violating the assumption of risk for multicollinearity
by testing all behaviors in one model.
Higher overall adherence to daily weighing was associated
with a poorer overall kidney function (GFRcrea t :
F(1,363.87) = 9.05; β = − .17, P = .003), while there was no
significant effect of change daily weighing on change in
GFRcreat (F(1, 306.81) = 2.86; β = − .02, P = .092). Limiting
the daily consumption of fluids has both a significant
between- and within-subjec t e ffec t on GFRcr e a t
(F b e t w e e n ( 1362 . 48 ) = 7 . 58 ; β = − . 1 5 , P = .006 ;
Fwithin(1304.20) = 6.09; β = − .03, P = .014 respectively).
Multivariable results showed that increases in daily weight
monitoring over time showed a trend association with in-
creases in TNF-α (F(1,209.62) = 3.50; β = .08, P = .063).
Lower levels of sodium intake were significantly associated
with lower overall concentrations of Hb (F(1,379.78 = 4.94;
β = − .10, P = .027), TNF-alpha (F(1,257.26 = 6.64; β = − .14,
P = .011), and IL-10 (F(1,266.54 = 4.85; β = − .07, P = .029).
Change in sodium intake was unrelated to change in these
biomarkers. In contrast, a generally better adherence to regular
physical exercise was associated with lower levels of IL-6
(F(1,258.84) = 13.64; β = − .21, P < .001), and improvement
in regular physical exercise was significantly associated with
improvements in kidney function (i.e., higher GFRcreat;
β = .04, P = .002) and in Hb (β = .06, P < .001). Positive
change in consulting behavior was associated with a reduction
in creatinin clearance (β = − .03, P = .032).
The person mean of medication adherence was negatively
related to overall levels of TNF-alpha (F(1,256.44) = 12.05;
Table 3 Descriptive information on biomarkers at baseline and change at follow-up
Patients who improved in
overall self-care (N = 158)
Patients with stable overall
self-care (N = 36)
Patients who reduced in
overall self-care (N = 151)
GFRcreat level (ml/min/1.73m
2) 67.1 (21.7) 69.5 (20.2) 71.4 (23.3)
ΔGFRcreat (ml/min/1.73m
2) − 1.5 (14.8) .2 (9.9) .02 (14.1)
Hb level (g/dl) 8.7 (.9) 8.8 (.7) 8.7 (.9)
ΔHb (g/dl) − .03 (.7) .1 (.8) − .1 (.9)
TNF-ɑ level (pg/ml) 14.4 (9.9) 14.4 (8.6) 12.8 (6.8)
ΔTNF-ɑ (pg/ml) 1.8 (19.6) 5.7 (15.5) .36 (4.7)
IL-6 level (pg/ml) 5.3 (4.4) 4.5 (2.7) 4.8 (4.1)
ΔIL-6 (pg/ml) − .11 (4.3) − 1.6 (4.0) .34 (5.4)
IL-10 level (pg/ml) 2.8 (2.4) 2.2 (1.2) 2.5 (2.5)
ΔIL-10 (pg/ml) .36 (2.1) − .16 (1.9) .51 (2.4)
Int.J. Behav. Med.
β = − .19, P = .001) and IL-6 (F(1,269.05) = 7.52; β = − .15,
P = .007). Improvement of medication adherence over time
though was not associated with changes in any of the markers
in multivariable analyses. Random intercepts were all
significant.
With respect to interactions with time, which were tested in
the final models, results showed few effects. The between-
subject effect of adherence to daily weighing was different for
IL-6 at baseline vs. at follow-up (F(1,216.88) = 4.77, β = .07,
P = .030, B = .03, se = .01), the effect at follow-up being larger.
Also for between-subject effects of medication adherence on
kidney function (F(1,306.34) = 7.30, β = .04, P = .007, B =
4.3, se = 1.6) and TNF-alpha (F(1,253.67) = 5.515, β = .08,
P = .006, B = .05, se = .02), we observed a similar interaction
with time. Positive changes in daily weighing significantly
interacted with time to affect hemoglobin (F(1,348.54) = 4.47,
β = .09, P = .035, B = .25, se = .12), and positive changes in
fluid restriction significantly interacted with time to affect kid-
ney function (F(1,362.15) = 4.59, β = .12, P = .035, B = 9.8,
se = 4.6) and IL-6 (F(1,250.20) = 5.73, β = − .12, P = .017,
B = − .10, se = .04). The effects of consultation behavior, salt
restriction, and exercise did not interact with time.
Table 4 Longitudinal
associations of total self-care and
continuous levels of GFRcreat and
hemoglobin
GFRcreat Hemoglobin
B t P B t P
Time − .42 − .48 .632 − .06 − 1.30 .195
Model 1
Self-care between − .24 − 2.54 .012 − .003 − 1.29 .198
Self-care within − .09 − 2.01 .045 .004 1.76 .079
Time − .51 − .65 .518 − .06 − 1.45 .149
Model 2
Self-care between − .21 − 2.33 .020 − .002 − .83 .408
Self-care within − .09 − 2.04 .042 .005 1.81 .071
Time − .52 − .66 .512 − .07 − 1.57 .117
Age − 1.19 − 6.43 < .001 − .009 − 1.83 .069
Male gender 4.11 1.03 .303 .60 5.86 < .001
Partner status (yes) − 2.08 − .53 .600 .05 .49 .624
Education .27 .10 .922 .07 .76 .447
Smoking − .78 − .19 .846 .18 1.72 .086
BMI − .45 − 1.30 .194 .02 1.88 .061
Model 3
Self-care between − .21 − 2.28 .023 − .001 − .44 .662
Self-care within − .09 − 2.04 .042 .005 1.79 .075
Time − .48 − .60 .547 .06 1.32 .190
Age − 1.11 − 6.08 < .001 − .006 − 1.28 .202
Male gender 4.17 1.06 .289 .55 5.51 < .001
Partner status (yes) 2.88 .84 .460 .02 .16 .876
Education* − .01 − .002 .998 .11 1.26 .208
Smoking .77 .19 .846 .15 1.48 .140
BMI − .42 − 1.22 .223 .02 2.77 .006
Diabetes − 2.15 − .56 .574 − .24 − 2.57 .010
Time since diagnosis − .27 − 1.05 .294
RAAS medication 2.60 .55 .583 .10 .83 .410
Diuretics − 9.31 − 2.47 .014 − .23 − 2.44 .015
NYHA class III .73 .20 .842 − .44 − 4.71 < .001
LVEF .52 2.04 .042 − .008 − 1.3 .194
Aspirin 5.73 1.73 .085 .05 .55 .582
GFRcreat glomerular filtration rate of creatinine, LVEF left ventricular ejection fraction, NYHA New York Heart
Association, RAAS renin-angiotensin-aldosterone system. Boldfaced numbers represent significant differences
(P<.05), while italic numbers represent trends (P<.10).
*More than primary school
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Fig 2 Pearson correlations
between individual self-care be-
haviors and pathophysiological




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































To our knowledge, this is the first prospective study that ex-
amined the association of HF self-care and important patho-
physiological processes related to inflammation, cardiorenal,
and hematological function in patients with chronic HF. We
found a prospective association between better global self-
care and worse renal function beyond other clinical covariates,
such as HF disease severity and diabetes. Significant within-
subject effects of self-care were found for GFRcreat for the total
scale and for behaviors important for renal function, i.e., daily
weighing and limiting fluids. This means that when patients’
self-care behaviors improved over time, their renal function
became poorer. Global self-care was unrelated to Hb or in-
flammatory markers. In line with the literature [25–29], regu-
lar physical exercise was associated with less inflammation
and an improvement in exercise to improvement in hemato-
logical and renal function. In contrast, fluid and sodium re-
striction were associated with poorer renal and hematological
function. Low sodium intake was associated with lower TNF-
alpha and IL-10.
Against initial expectations, we found no evidence for
a relation between global self-care (i.e., the total score)
and levels of pathophysiological markers with the excep-
tion of renal dysfunction. A possible explanation may be
that self-care as assessed by the EHFScB-9 does not
represent a homogeneous construct, especially not in
the context of explanatory mechanisms and HF out-
comes. While the psychometric reliability for the total
self-care scale is good, this seems most contributable to
the high internal consistency of the consultation subscale.
When examining the associations of the individual self-
care behaviors with levels of pathophysiological markers,
distinctive and even contrasting patterns were found that
possibly serve as an explanation for the lack of associa-
tions found for global self-care.
Our findings are consistent with the notion that HF signs
and symptoms may play an important role in driving self-care
in chronic diseases [9, 30]. The necessity of performing health
behaviors tomonitor andmanage symptoms becomes relevant
or perhaps is instructed by health care providers once HF
pathogenic function starts to worsen. This is in line with the
findings reported by Lee et al. who found that HF patients
performing well with regard to self-care management were
at increased risk for myocardial stress and inflammation [9].
Patients who improved their self-care in our study did so
across the board and particularly in terms of daily weight
monitoring and fluid and salt restriction, which may become
especially relevant when HF progresses. Improvement in fluid
restriction was associated with a deterioration of renal func-
tion in our study. From these and our current findings, it
should be examined whether patients need to alter their self-
care habits in an earlier, perhaps preclinical phase of their
disease. It is possible that increased self-care in patients with
HF involves an appropriate response to disease progression
and thus represents a clear marker of worsening clinical con-
dition. Clinicians may want to train patients in good self-
management before the clinical condition worsens, and before
self-care is motivated by symptom severity.
Regular physical exercise was consistently associated with
m o r e f a v o r a b l e l e v e l s a n d im p r o v em e n t o f
pathopathophysiological markers beyond clinical parameters,
emphasizing the importance of physical activity to maintain
health in HF [29]. In contrast, weight monitoring and fluid
restriction were associated with cardiorenal dysfunction, and
sodium restriction with lower Hb concentrations.
Counterintuitively, though supported by literature [29–31],
our results may also suggest a potential harmful effect of ex-
tensive dietary restricting behaviors on levels of pathophysio-
logical markers in patients with HF. It is unclear whether all
self-care behaviors are equally beneficial within each phase of
HF disease progression and/or for every patient. Given that
chronic HF is a complex systemic disease, patients varying in
disease severity may respond differently to self-care behav-
iors. Importantly, recommendations on the level of sodium
restriction have beenmainly based on research among patients
with hypertension [30] and to a lesser extent on patients with
HF. Recent studies increasingly show that the amount of so-
dium intake and HF disease severity are important factors to
consider in terms of long-term prognosis. For example, a <
3 g/day sodium intake was only beneficial in terms of prog-
nosis in patients with advanced HF (NYHA function class III
or IV) and not in patients with mild HF [32, 33]. Another
study showed that (too) strict sodium restriction of < 1.8 g/
day was associated with activation of neurohormones and
cytokines, and body dehydration, thus worsening outcomes
in patients with advanced HF [34]. In our current study, fluid
and sodium restriction and prescribed diuretics were associat-
ed with worse pathophysiological function, and positive
change in behavior actually was associated with a worsening.
While we assessed self-care by means of self-report, our find-
ings conform to the results from studies that assessed fluid and
sodium restriction with objective measures, e.g., with 24-h
urine collection logs. A critical examination of the potential
harms and benefits of fluid and sodium restriction and diuretic
dose in terms of long-term prognosis may be needed while
considering the different stages of HF disease severity in fu-
ture research. Also, for clinical practise, these results suggest
to be mindful to the patient context in which one prescribes
salt restriction and to what extent.
Renal dysfunction, neurohormonal and pro-inflammatory
activation, and anemia are complexly interacting systems in
the pathogenesis of HF [12]. With respect to cytokines, IL-6
concentrations affect TNF-α (−) and IL-10 (+) concentrations.
Pro-inflammatory cytokines, in turn, are inversely associated
with Hb concentrations and contribute to anemia via multiple
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mechanisms. For example, TNF-α and IL-6 inhibit erythro-
poietin production in the kidney, as well as the function of
erythroid progenitor cells in bone marrow [35–37]. These mu-
tual interactions may also affect their relations with self-care,
which may explain the lack of a unified finding. Future re-
search is needed to examine these potential interacting
mechanisms.
Reporting to perform regular physical exercise was robust-
ly associated with less inflammation, and a positive change in
exercise behavior to improvement in hematological and renal
function conforms prior literature [25–29]. Cause and effect
are as yet not clear. There has been a study suggesting that
weight loss is mediating the association between exercise and
reduced inflammation [38].
In accordance with previous findings, several socio-
demographic and clinical covariates of pathophysiologi-
cal outcomes were found. Diabetes, a well-known risk
factor for HF disease progression [39–41], was associat-
ed with increased inflammation and poor hematological
function. Increasing age was associated with increased
systemic inflammation and renal dysfunction. Higher
NYHA functional class, female sex, and prescribed di-
uretics were associated with lower Hb concentrations
which has been reported previously (e.g., [12, 28]).
Other significant predictors of renal dysfunction were
lower LVEF and prescribed diuretics. Increasing BMI
was associated with increased systemic inflammation,
but also with better hematological function. This latter
finding fits the “obesity paradox” in HF, a phenomenon
showing that overweight and mild/moderate obesity are
associated with a mortality benefit with complex under-
lying pathophysiological processes [42].
Current findings should be interpreted in light of several
limitations. First, self-care was assessed by self-report,
which is an easy and preferred clinical assessment method,
but may not reflect actual behavior. Moreover, individual
behaviors were reported as the degree to which patients
agreed they performed the ideal self-care behavior (e.g., I
weigh myself every day, I perform regular exercise). The
limitation to these kinds of questions is that frequency of
the behavior often remains unclear. Self-report measures
are complicated by systematic biases and it is recommend-
ed to include multiple measurement strategies to assess
self-care behavior [43]. Also, we used single items to ex-
amine individual self-care behaviors. While there are sev-
eral limitations to the use of single-item measures, they are
reliable as health measures [44]. As blood collection
started at a later time point within the study data collection,
cytokine levels were assessed in a subsample of patients
who were characterized by better cardiac function. We took
these clinical differences into account by including cardiac
disease severity in our multivariable analyses. We, howev-
er, did not examine random slopes, i.e., testing that
different patients have different biomarker trajectories over
time. Future studies may want to examine this individual-
specific variation in pathophysiological function over time
in a sample with a longer follow-up period and more as-
sessment occasions in a denser pattern than the current
study. With respect to the random effects analysis, we only
estimated random intercepts, but no random slopes, as we
had no a priori hypothesis on patient-specific slopes in the
association of self-care and biomarkers. This decision not
to fit random slopes could have resulted in an inflated type-
I error rate when random slopes would be present [45].
Future research may want to examine random slopes for
groups of patients though (e.g., improving vs. stable vs.
progressing patients). Finally, patients with complete data
were in better cardiac condition and with fewer comorbid-
ities than patients who dropped out, while baseline self-
care scores were similar. The retention of a healthier sam-
ple in the study may have led to an underestimation of the
effect of self-care on biomarker levels at follow-up.
In conclusion, our findings suggest global self-care
and improvement in global self-care were associated with
poorer and deteriorating renal dysfunction respectively
(i.e., lower GFRcreat) in a large cohort of patients with
chronic HF, indicating that the level of self-care may
reflect an appropriate response to disease progression.
No associations were found between global self-care
and respectively Hb concentrations and inflammation.
Performing self-care behaviors such as regular exer-
cise and medication adherence was associated with im-
proved physiological functioning, while restriction of flu-
id and sodium, and the associated daily weight monitor-
ing were associated with adverse levels of pathophysio-
logical biomarkers.
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